NCT06072989View on ClinicalTrials.gov

Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2027

Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL

B4T2-001 autologous CAR-T

Each subject will receive multiple intravenous infusions of B4T2-001 autologous CAR-T without preparative chemotherapy (lymphodepletion)

Trial Locations (2)

200126

RECRUITING

Shanghai East Hospital, Shanghai

200131

RECRUITING

Shanghai Artemed Hospital, Shanghai

All Listed Sponsors
collaborator

Bio4T2 LLC

INDUSTRY

lead

Shanghai East Hospital

OTHER